Insulin degrading enzyme and alpha-3 catenin polymorphisms in Italian patients with Alzheimer disease

Alzheimer Disease and Associated Disorders

Volumn 19, Issue 4, 2005, Pages 246-247

  Cellini, Elena ^a   Bagnoli, Silvia ^a   Tedde, Andrea ^a   Nacmias, Benedetta ^a   Piacentini, Silvia ^a   Sorbi, Sandro ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CATENIN; AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E; INSULINASE; PRESENILIN 1; CTNNA3 PROTEIN, HUMAN;

ALLELE; ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; CHROMOSOME 10Q; COMPUTER PROGRAM; CORRELATION ANALYSIS; DISEASE SEVERITY; DNA MODIFICATION; GENETIC ANALYSIS; GENETIC CODE; GENETIC HETEROGENEITY; GENETIC LINKAGE; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; ITALY; LETTER; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN INTERACTION; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; AGED; CASE CONTROL STUDY; GENETICS; MIDDLE AGED;

AGED; ALPHA CATENIN; ALZHEIMER DISEASE; CASE-CONTROL STUDIES; HUMANS; INSULYSIN; ITALY; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 33644968179     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.wad.0000189030.50826.86     Document Type: Letter

References (12)

1. Bertram L, Blacker D, Mullin K, et al. Evidence for genetic linkage of Alzheimer's disease to chromosome 10q. Science. 2000;290:2302-2303.
2. Ertekin-Taner N, Ronald J, Asahara H, et al. Fine mapping of the alpha-T catenin gene to a quantitative trait locus on chromosome 10 in late-onset alzheimer's disease pedigrees. Hum Mol Genet. 2003;2:3133-3143.
3. Edland SD, Wavrant-De Vriese F, et al. Insulin degrading enzyme (IDE) genetic variants and risk of Alzheimer's disease: evidence of effect modification by apolipoprotein E (APOE). Neurosci Lett. 2003;345:212-214.
4. Zhang Z, Hartmann H, Do VM, et al. Destabilization of beta-catenin by mutations in presenilin-1 potentiates neuronal apoptosis. Nature. 1998;395:698-702.
5. Feuk L, McCarthy S, Andersson B, et al. Mutation screening of a haplotype block around the insulin degrading enzyme gene and association with Alzheimer's disease. Am J Med Genet B Neuropsychiatr Genet. 2005;136:69-71.
6. Nowotny P, Hinrichs AL, Smemo S, et al. Association studies between risk for late-onset alzheimer's disease and variants in insulin degrading enzyme. Am J Med Genet B Neuropsychiatr Genet. 2005;136:62-68.
7. Blomqvist ME, Chalmers K, Andreasen N, et al. Sequence variants of IDE are associated with the extent of beta-amyloid deposition in the Alzheimer's disease brain. Neurobiol Aging. 2005;26:795-802.
8. Ertekin-Taner N, Allen M, Fadale D, et al. Genetic variants in a haplotype block spanning IDE are significantly associated with plasma Abeta42 levels and risk for Alzheimer disease. Hum Mutat. 2004;23:334-342.
9. Busby V, Goossens S, Nowotny P, et al. Alpha-T-catenin is expressed in human brain and interacts with the Wnt signaling pathway but is not responsible for linkage to chromosome 10 in Alzheimer's disease. Neuromolecular Med. 2004;5:133-146.
10. Boussaha M, Hannequin D, Verpillat P, et al. Polymorphisms of insulin degrading enzyme gene are not associated with Alzheimer's disease. Neurosci Lett. 2002;329:121-123.
11. Blomqvist ME, Andreasen N, Bogdanovic N, et al. Genetic variation in CTNNA3 encoding alpha-3 catenin and Alzheimer's disease. Neurosci Lett. 2004;358:220-222.
12. The Dementia Study Group of the Italian Neurological Society. Guidelines for the diagnosis of dementia and Alzheimer's disease. Ital J Neurol Sci. 2000;21:187-194.